Armstrong Advisory Group’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.68K Hold
93
– – ﹤0.01% 836
2026
Q2
$3.15K Hold
93
– – ﹤0.01% 842
2026
Q1
$2.8K Hold
93
– – ﹤0.01% 840
2025
Q4
$2.9K Hold
93
– – ﹤0.01% 826
2025
Q3
$1.88K Buy
+93
New +$1.63K ﹤0.01% 866

Other funds holding TEVA

Armstrong Advisory Group's TEVA Position: Q3 2026 in Review

Armstrong Advisory Group held its Teva Pharmaceutical Industries (TEVA) position steady in Q3 2026 at 93 shares worth $3.68K. The position accounts for ﹤0.01% of the portfolio, ranked #836.

Armstrong Advisory Group first reported a position in TEVA in Q3 2025 and has held it in 5 quarters since. 598 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Armstrong Advisory Group held 93 shares of Teva Pharmaceutical Industries worth $3.68K as of Q3 2026.
  • Armstrong Advisory Group left its Teva Pharmaceutical Industries share count unchanged in Q3 2026.
  • Teva Pharmaceutical Industries made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #836 holding.
  • Armstrong Advisory Group first reported a position in Teva Pharmaceutical Industries in Q3 2025 and has held it in 5 quarters since.
  • 598 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.